Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.
Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.
Quoin製藥的股票上漲，因爲公司宣佈已獲得FDA批准啓動新的QRX003奈瑟頓綜合症臨牀研究。
Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.
Quoin製藥的股票上漲，因爲公司宣佈已獲得FDA批准啓動新的QRX003奈瑟頓綜合症臨床研究。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間